Latest News
MDimune Named as a Finalist in the Prestigious 2023 Edison Awards™
MDimune announced the development of the GMP manufacturing process CDVs in the latest publication
MDimune announced a collaboration with Hanyang University through the 3rd BioDrone™ Award
Feb 22, 2023 BioDrone™ next-generation drug delivery platform honored for excellence alongside other innovators and innovations in the Health, Medical & Biotech category
MDimune announced a collaboration with Hanyang University through the 3rd BioDrone™ Award
MDimune announced the development of the GMP manufacturing process CDVs in the latest publication
MDimune announced a collaboration with Hanyang University through the 3rd BioDrone™ Award
Jan 26, 2023 MDimune Inc. announced funding of two research projects focusing on next-generation drug delivery and novel therapeutics.
MDimune announced the development of the GMP manufacturing process CDVs in the latest publication
MDimune announced the development of the GMP manufacturing process CDVs in the latest publication
MDimune announced the development of the GMP manufacturing process CDVs in the latest publication
Jan 5, 2023 MDimune Inc. announced the publication of data in the Journal of Extracellular Biology showing the development of the Good Manufacturing Practice (GMP)-compliant manufacturing process of CDVs and their biological activities.
About Us
BioDrone™ Platform Technology
BioDrone™ Platform Technology
BioDrone™ Platform Technology
Groundbreaking drug delivery platform that precisely delivers various drugs to targeted lesions by loading them into cell-derived vesicles (CDVs) derived from human cells.
Business Model
BioDrone™ Platform Technology
BioDrone™ Platform Technology
MDimune is currently seeking partners for R&D collaborations that utilize the BioDrone™ (CDVs) platform for next-generation cell therapies or targeted payload delivery.
Open Innovation
BioDrone™ Platform Technology
Open Innovation
Platform Inside Development Outside (PIDO) model to collaborate with pharma/biotech partners in diverse therapeutic areas (cancer, rare diseases, CNS disorders, etc.).